NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Shook, MD
Nkarta, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- the Cleveland Clinic - Taussig Cancer Institute
Cleveland, Ohio, United States
- Sarah Cannon at Tristar Bone Marrow Transplant Center
Nashville, Tennessee, United States
- Md Anderson Cancer Center, University of Texas
Houston, Texas, United States
- Methodist Healthcare System of San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Sept 2020
- Primary completion
- 2 Oct 2024
- Completion
- 31 Jul 2039
- Last update posted
- 27 Dec 2024
- Registered enrollment
- 61
- Registry id
- NCT04623944
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.